GLP-1 weight loss injections are typically recommended for individuals who: Have a Body Mass Index (BMI) of 30 or higher (obesity) or a BMI of 27 or higher with an obesity-related condition (like type 2 diabetes, hypertension, or high cholesterol), have difficulty losing weight through diet and exercise alone, have type 2 diabetes and need better blood sugar control along with weight management
The patches are promoted as a convenient alternative to pills, powders, gels, drinks, gummies or needles that deliver GLP-1-stimulating ingredients through your skin. Key claims include appetite suppression, metabolism support, blood sugar regulation, and healthy weight loss without losing muscle. However, these claims require careful examination against what we know about transdermal drug delivery and the ingredients actually contained in the patches
Clinical studies have shown that Wegovy, a different dosage of semaglutide, the drug found in Ozempic and Rybelsus, is effective in lowering the risk of cardiovascular events in those who are overweight or obese
You Might Go Through Hell for Your Post-Ozempic Body
Safe use of GLP-1 therapy hinges on close medical supervision and frequent kidney function tests
